BioIVT

Pre-analytical variation remains one of the biggest challenges in #LiquidBiopsy #biomarker research. Watch our recent presentation to learn how teams can build more trial-ready liquid biopsy workflows: hubs.ly/Q04fgx790

What will it take to make #AlzheimersDiagnostics more accessible? In BioIVT’s recent webinar, we explore the comprehensive approach needed to move #Alzheimers #diagnostics forward: hubs.ly/Q04fgvmL0 #AlzheimersResearch #pTau217 #pTau181 #biomarkers

Using disease-state raw cellular starting materials offers a unique opportunity to advance #AdvancedTherapies for #autoimmune conditions. These cells provide valuable insights into disease mechanisms, disease modeling & targeted therapy development: hubs.ly/Q04fgr0k0

Choosing #NewApproachMethodologies (#NAMs) for your research isn’t simply about adopting new technologies. Take a deeper look at what to consider when selecting a NAM: hubs.ly/Q04dx0sQ0

Attending the #SanFrancisco #PBSS #DMPK & #Bioanalytical Technologies Symposium? Make sure to visit our team to talk all things #ADME and catch Joanna Barbara, PhD presenting on #Metabolite profiling of #GLP1 agonist peptide drugs in human liver lysosomes at 3:50pm!

We’re looking forward to the #GLDMDG next week! Make sure to connect with our team if you’d like to meet and don’t miss our presentation: hubs.ly/Q04dwSgF0 #ADME #GLP1 #DrugMetabolism #Lysosomes

Accelerated timelines and resourcing constraints are putting pressure on dermatology research. BioIVT serves as a trusted provider for a range of skin tissues and cells to meet your research needs – Tissue: hubs.ly/Q04dwV-R0 Cells: hubs.ly/Q04dwTw80

#CARTcell therapy has already changed what’s possible in cancer treatment, but many hurdles still remain. In our latest blog, ‘The Next Frontier of CAR-T Therapy’, we break down the key trends, overcoming challenges and what’s ahead in CAR-T therapy: hubs.ly/Q04dwVPw0

May is going to be packed full of great events again! Take a look at some of the conferences where you can connect with our experts and see our presentation lineup: hubs.ly/Q04dKLvq0 #DMDG #MPSWorldSummit #ASGCT2026 #SIDChicago26 #EASLCongress

Our VP of Scientific Affairs highlights how factors like collection timing, freeze-thaw cycles & storage conditions influence biospecimen quality & downstream results. Watch the full video to learn more ➡️ hubs.ly/Q04dwPpj0 #Biomarkers #PrecisionMedicine

This World Day for #LaboratoryAnimals highlights the continued progress toward more precise, data-driven research approaches that reduce reliance on animal testing. Learn more about #NewApproachMethodologies (#NAMs): hubs.ly/Q04cKqVS0

With ~10M people living with #Parkinsons worldwide and that # expected to double by 2050, #ParkinsonsAwareness Month underscores the urgent need to support PD research. Learn about BioIVT’s #neuroscience #biospecimens & let us know how we can support you: hubs.ly/Q04cKHx70

The next chapter of #CellandGeneTherapy will be shaped not just by scientific breakthroughs, but by the industry’s ability to industrialize, harmonize & democratize these technologies: hubs.ly/Q04cKpCb0 #AdvancedTherapies #ATMPs #CellTherapy

Join BioIVT’s Joanna Barbara, PhD at the #SanFrancisco #PBSS Vendor Scientific Highlights Symposium where she’ll be presenting on #Metabolite profiling of #GLP1 agonist peptide drugs in human liver #lysosomes: hubs.ly/Q04cXTHh0 #ADME #DrugMetabolism

Evidence suggests patients respond differently to #GLP1 therapy based on #demographics. We offer #biospecimens collected from patients on the newest treatments or segmented across weight categories, BMI, waist circumference & more to support this research: hubs.ly/Q04cKpJk0

We’ve all heard “quality beats quantity,” but when it comes to data, we really need both. Learn about how #digitalpathology is enabling #AI to unlock #precisionmedicine breakthroughs: hubs.ly/Q04cKpjV0 Or visit our team at #AACR2026 booth #4547 to discuss in person!

Our team is ready at #AACR2026 booth #4547 to discuss how we can help ensure the accuracy of your research with our comprehensive, high-quality, richly annotated, healthy controls and pathologist-reviewed #oncology #biospecimens, data solutions, and services. See you there!

BioIVT is excited to partner with @SEQSTER to support a more complete approach to help deliver deeper insights into how therapies perform in the real world. Read the full announcement: hubs.ly/Q04clFFj0

Our team is at #IMMUNOLOGY2026 booth #1036 to help you source healthy or disease-state, high quality, RUO & GMP-compliant #Leukopaks & #ImmuneCells, ethically sourced from a diverse, global donor network featuring 700+ HLA-typed, highly characterized & recallable donors! #AAI2026

#HSC yields can be impacted by mobilization, donor demographics and other biological factors, so we analyzed donors undergoing single and dual mobilization regimens and broke the data down across a variety of potential influencers – take a look: hubs.ly/Q04bXPSm0 #HSPCs